These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19032070)

  • 1. Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection.
    Jensen TB; Gottwein JM; Scheel TK; Hoegh AM; Eugen-Olsen J; Bukh J
    J Infect Dis; 2008 Dec; 198(12):1756-65. PubMed ID: 19032070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.
    Scheel TK; Gottwein JM; Jensen TB; Prentoe JC; Hoegh AM; Alter HJ; Eugen-Olsen J; Bukh J
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):997-1002. PubMed ID: 18195353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
    Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
    Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.
    Gottwein JM; Scheel TK; Jensen TB; Lademann JB; Prentoe JC; Knudsen ML; Hoegh AM; Bukh J
    Hepatology; 2009 Feb; 49(2):364-77. PubMed ID: 19148942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.
    Mathiesen CK; Prentoe J; Meredith LW; Jensen TB; Krarup H; McKeating JA; Gottwein JM; Bukh J
    J Virol; 2015 Aug; 89(15):7758-75. PubMed ID: 25995244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
    Lavillette D; Tarr AW; Voisset C; Donot P; Bartosch B; Bain C; Patel AH; Dubuisson J; Ball JK; Cosset FL
    Hepatology; 2005 Feb; 41(2):265-74. PubMed ID: 15660396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations.
    Scheel TK; Gottwein JM; Carlsen TH; Li YP; Jensen TB; Spengler U; Weis N; Bukh J
    J Virol; 2011 Mar; 85(6):2891-906. PubMed ID: 21177811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
    Gottwein JM; Bukh J
    Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An adaptive mutation in NS2 is essential for efficient production of infectious 1b/2a chimeric hepatitis C virus in cell culture.
    Chan K; Cheng G; Beran RK; Yang H; Appleby TC; Pokrovskii MV; Mo H; Zhong W; Delaney WE
    Virology; 2012 Jan; 422(2):224-34. PubMed ID: 22099378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A point mutation at Asn-534 that disrupts a conserved N-glycosylation motif of the E2 glycoprotein of hepatitis C virus markedly enhances the sensitivity to antibody neutralization.
    Sasayama M; Shoji I; Adianti M; Jiang DP; Deng L; Saito T; Watanabe H; Kawata S; Aoki C; Hotta H
    J Med Virol; 2012 Feb; 84(2):229-34. PubMed ID: 22170542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies.
    Fournier C; Duverlie G; François C; Schnuriger A; Dedeurwaerder S; Brochot E; Capron D; Wychowski C; Thibault V; Castelain S
    Virol J; 2007 Mar; 4():35. PubMed ID: 17397531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins.
    Ishii K; Murakami K; Hmwe SS; Zhang B; Li J; Shirakura M; Morikawa K; Suzuki R; Miyamura T; Wakita T; Suzuki T
    Biochem Biophys Res Commun; 2008 Jul; 371(3):446-50. PubMed ID: 18445476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studies.
    Humes D; Ramirez S; Jensen TB; Li YP; Gottwein JM; Bukh J
    Virology; 2018 Sep; 522():177-192. PubMed ID: 30032031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus.
    Yi M; Ma Y; Yates J; Lemon SM
    J Virol; 2007 Jan; 81(2):629-38. PubMed ID: 17079282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3/4A protease recombinant viruses.
    Gottwein JM; Scheel TK; Jensen TB; Ghanem L; Bukh J
    Gastroenterology; 2011 Sep; 141(3):1067-79. PubMed ID: 21699793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A.
    Gottwein JM; Jensen TB; Mathiesen CK; Meuleman P; Serre SB; Lademann JB; Ghanem L; Scheel TK; Leroux-Roels G; Bukh J
    J Virol; 2011 Sep; 85(17):8913-28. PubMed ID: 21697486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of hepatitis C virus core/NS5A protein co-localization using novel cell culture systems expressing core-NS2 and NS5A of genotypes 1-7.
    Galli A; Scheel TKH; Prentoe JC; Mikkelsen LS; Gottwein JM; Bukh J
    J Gen Virol; 2013 Oct; 94(Pt 10):2221-2235. PubMed ID: 23907394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C virus].
    Querenghi F; Zoulim F
    Rev Prat; 2000 May; 50(10):1060-5. PubMed ID: 10905089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.
    Li YP; Ramirez S; Mikkelsen L; Bukh J
    J Virol; 2015 Jan; 89(1):811-23. PubMed ID: 25355880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6-mediated intersubgenotypic variation of interferon sensitivity in hepatitis C virus genotype 2a/2b chimeric clones.
    Suda G; Sakamoto N; Itsui Y; Nakagawa M; Tasaka-Fujita M; Funaoka Y; Watanabe T; Nitta S; Kiyohashi K; Azuma S; Kakinuma S; Tsuchiya K; Imamura M; Hiraga N; Chayama K; Watanabe M
    Virology; 2010 Nov; 407(1):80-90. PubMed ID: 20797756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.